TY - JOUR
T1 - Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model
AU - Wendel, Jacqueline S.
AU - Ye, Lei
AU - Zhang, Pengyuan
AU - Tranquillo, Robert T.
AU - Zhang, Jianyi Jay
PY - 2014/4/1
Y1 - 2014/4/1
N2 - Cell therapies have emerged as a promising treatment for the prevention of heart failure after myocardial infarction (MI). This study evaluated the capacity of an aligned, fibrin-based, stretch-conditioned cardiac patch consisting of either the native population or a cardiomyocyte (CM)-depleted population (i.e., CM+ or CM- patches) of neonatal rat heart cells to ameliorate left ventricular (LV) remodeling in the acute-phase postinfarction in syngeneic, immunocompetent rats. Patches were exposed to 7 days of static culture and 7 days of cyclic stretching prior to implantation. Within 1 week of implantation, both patches became vascularized, and non-CMs began migrating from CM+ patches. By week 4, patches had been remodeled into collagenous tissue, and live, elongated, donor CMs were found within grafted CM+ patches. Significant improvement in cardiac contractile function was seen with the administration of the CM+ patch (ejection fraction increased from 35.1%±4.0% for MI only to 58.8%±7.3% with a CM+ patch, p<0.05) associated with a 77% reduction in infarct size (61.3%±7.9% for MI only, 13.9%±10.8% for CM+ patch, p<0.05), and the elimination of LV free-wall thinning. Decreased infarct size and reduced wall thinning also occurred with the administration of the CM- patch (infarct size 36.9%±10.2%, LV wall thickness: 1058.2±135.4μm for CM- patch, 661.3±37.4μm for MI only, p<0.05), but without improvements in cardiac function. Approximately 36.5% of the transplanted CMs survived at 4 weeks; however, they remained separated and electrically uncoupled from the host myocardium by a layer of CM-free tissue, which suggests that the benefits of CM+ patch transplantation resulted from paracrine mechanisms originating from CMs. Collectively, these observations suggest that the transplantation of CM-containing engineered heart tissue patches can lead to dramatic improvements in cardiac function and remodeling after acute MI.
AB - Cell therapies have emerged as a promising treatment for the prevention of heart failure after myocardial infarction (MI). This study evaluated the capacity of an aligned, fibrin-based, stretch-conditioned cardiac patch consisting of either the native population or a cardiomyocyte (CM)-depleted population (i.e., CM+ or CM- patches) of neonatal rat heart cells to ameliorate left ventricular (LV) remodeling in the acute-phase postinfarction in syngeneic, immunocompetent rats. Patches were exposed to 7 days of static culture and 7 days of cyclic stretching prior to implantation. Within 1 week of implantation, both patches became vascularized, and non-CMs began migrating from CM+ patches. By week 4, patches had been remodeled into collagenous tissue, and live, elongated, donor CMs were found within grafted CM+ patches. Significant improvement in cardiac contractile function was seen with the administration of the CM+ patch (ejection fraction increased from 35.1%±4.0% for MI only to 58.8%±7.3% with a CM+ patch, p<0.05) associated with a 77% reduction in infarct size (61.3%±7.9% for MI only, 13.9%±10.8% for CM+ patch, p<0.05), and the elimination of LV free-wall thinning. Decreased infarct size and reduced wall thinning also occurred with the administration of the CM- patch (infarct size 36.9%±10.2%, LV wall thickness: 1058.2±135.4μm for CM- patch, 661.3±37.4μm for MI only, p<0.05), but without improvements in cardiac function. Approximately 36.5% of the transplanted CMs survived at 4 weeks; however, they remained separated and electrically uncoupled from the host myocardium by a layer of CM-free tissue, which suggests that the benefits of CM+ patch transplantation resulted from paracrine mechanisms originating from CMs. Collectively, these observations suggest that the transplantation of CM-containing engineered heart tissue patches can lead to dramatic improvements in cardiac function and remodeling after acute MI.
UR - http://www.scopus.com/inward/record.url?scp=84898484169&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898484169&partnerID=8YFLogxK
U2 - 10.1089/ten.tea.2013.0312
DO - 10.1089/ten.tea.2013.0312
M3 - Article
C2 - 24295499
AN - SCOPUS:84898484169
SN - 1937-3341
VL - 20
SP - 1325
EP - 1335
JO - Tissue Engineering - Part A
JF - Tissue Engineering - Part A
IS - 7-8
ER -